$XCRT Xcelerate, Inc. Announces Commencement of th
Post# of 25228
![Avatar](/images/ProfileImages/1556287445_32333_stitch_pleased_avatar_picture_13166.jpg)
https://www.accesswire.com/905830/xcelerate-i...plications
MAULDIN, SC / ACCESSWIRE / August 22, 2024 / Xcelerate, Inc. (OTCQB:"XCRT"
![](/images/icons/icon_wink.gif)
Mike O'Shea, Xcelerate's CEO stated "In addition to our efforts to uplist our common stock for listing on Nasdaq, we are also focusing on the nationalization of our medical device patents. The nationalization of these patents is a significant advancement in Xcelerate's mission to leverage non-medical engineering advancements and intellectual property for clinical and medical care. Mr. O'Shea continued by stating "We are looking forward to using the European Unitary Patent Application Process for the first time. Unitary Patent Applications have been possible since June 2023 and allow filers to cover 17 member states of the European Union (EU) with a single application. This includes the EU's three largest economies: Germany, France, and Italy. Other markets which will be covered include China, Ireland, Japan, and Mexico."
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)